Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 18/20 | 0.59 |
| ▸ | FNTB | P49356 | 16/20 | 0.59 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.59 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7230318 | 0.92 | FNTA (0.52) | FNTAFNTBPGGT1B | |
| SCHEMBL155329 | 0.87 | FNTA (0.57) | FNTAFNTBPGGT1B | |
| SCHEMBL23802598 | 0.87 | FNTA (0.57) | FNTAFNTBPGGT1B | |
| Methane SCHEMBL20839372 | 0.86 | FNTA (0.56) | FNTAFNTBPGGT1B | |
| SCHEMBL8054373 | 0.86 | FNTA (0.59) | FNTAFNTBPGGT1B | |
| Ammonia Solution, Strong SCHEMBL2828987 | 0.86 | FNTA (0.56) | FNTAFNTBPGGT1B | |
| SCHEMBL6758812 | 0.84 | FNTA (0.42) | FNTAFNTBPGGT1B | |
| SCHEMBL15140423 | 0.83 | FNTA (0.41) | FNTAFNTBPGGT1B | |
| SCHEMBL28408953 | 0.82 | FNTA (0.57) | FNTAFNTBPGGT1B | |
| SCHEMBL1379701 | 0.82 | FNTA (0.48) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030470-B2 | Isolated nucleic acids encoding farnesyltransferase polypeptides | PERFORMANCE PLANTS, INC. (CA) | 2011-10-04 | — | — | US | disclosed |
| US-7951991-B2 | Expression vector comprising nucleotide sequences coding peptidase for use generating disease and drought resistant plants | BASF PLANT SCIENCE GMBH (DE) | 2011-05-31 | — | — | US | disclosed |
| US-20110065191-A1 | ISOLATED NUCLEIC ACIDS ENCODING FARNESYLTRANSFERASE POLYPEPTIDES | PERFORMANCE PLANTS, INC. (CA) | 2011-03-17 | — | — | US | disclosed |
| US-7786354-B2 | Compositions and methods of increasing stress tolerance in plants | PERFORMANCE PLANTS, INC. (CA) | 2010-08-31 | — | — | US | disclosed |
| EP-2123763-A1 | Compositions and methods of increasing stress tolerance in plants | Performance Plants, Inc. (CA) | 2009-11-25 | — | — | EP | disclosed |
| US-20090172839-A1 | Compositions and Methods of Increasing Stress Tolerance in Plants | PERFORMANCE PLANTS, INC. (CA) | 2009-07-02 | — | — | US | disclosed |
| EP-1390515-B1 | COMPOSITIONS AND METHODS OF INCREASING STRESS TOLERANCE IN PLANTS | PERFORMANCE PLANTS INC (CA) | 2009-04-22 | — | — | EP | disclosed |
| US-20080072350-A1 | Polynucleotides encoding plant prenyl proteases | BASF PLANT SCIENCE GMBH (DE) | 2008-03-20 | — | — | US | disclosed |
| US-7172881-B2 | Isolated nucleic acids encoding farnesyl transferase alpha | PERFORMANCE PLANTS, INC. (CA) | 2007-02-06 | — | — | US | disclosed |
| EP-1421197-A2 | CAAX PRENYL PROTEASE NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE THEREOF | Performance Plants, Inc. (CA) | 2004-05-26 | — | — | EP | disclosed |
| EP-1390515-A2 | COMPOSITIONS AND METHODS OF INCREASING STRESS TOLERANCE IN PLANTS | Performance Plants, Inc. (CA) | 2004-02-25 | — | — | EP | disclosed |
| US-20030204865-A1 | CaaX prenyl protease nucleic acids and polypeptides and methods of use thereof | PERFORMANCE PLANTS, INC. (CA) | 2003-10-30 | — | — | US | disclosed |
| US-20030167535-A1 | Compositions and methods of increasing stress tolerance in plants | PERFORMANCE PLANTS INC. (CA) | 2003-09-04 | — | — | US | disclosed |
| WO-2003012116-A2 | CAAX PRENYL PROTEASE NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE THEREOF | PERFORMANCE PLANTS, INC. (CA) | 2003-02-13 | — | — | WO | disclosed |
| WO-2002097097-A2 | COMPOSITIONS AND METHODS OF INCREASING STRESS TOLERANCE IN PLANTS | PERFORMANCE PLANTS, INC. (CA) | 2002-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065191-A1 | ISOLATED NUCLEIC ACIDS ENCODING FARNESYLTRANSFERASE POLYPEPTIDES | FNTA, FNTB, TENT4A | FNTA 1/4885FNTB 2/4885PGGT1B 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.